The potential cross-talking of different chemokine axis was warranted further investigation because of their significant influence on TME.61 In our orthotopic HCC animal models, systemic administration of VEGF-C promoted the intratumoral lymphangiogenesis and enhanced the efficacy of anti-PD-1 immunotherapy. This evidence concerns the gene VEGFC and hepatocellular carcinoma.